4//SEC Filing
Coman David 4
Accession 0001104659-21-124841
CIK 0001819113other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 9:58 PM ET
Size
7.8 KB
Accession
0001104659-21-124841
Insider Transaction Report
Form 4
Coman David
DirectorCEO and Director
Transactions
- Award
Common Stock
2021-10-06+723,320→ 723,320 total - Award
Stock Option
2021-10-06+3,848,459→ 3,848,459 totalExercise: $0.28Exp: 2030-04-30→ Common Stock (3,848,459 underlying)
Footnotes (2)
- [F1]Pursuant to the business combination of LifeSci Acquisition II Corp and Science 37, Inc. ("Old Science 37"), as contemplated by that certain agreement and plan of merger, dated May 6, 2021 (the "Merger Agreement"), (a) each share of common stock of Old Science 37 outstanding immediately prior to the effective time of the business combination was converted into approximately 1.8153 shares of the Issuer's Common Stock (the "Conversion Ratio"); and (b) each outstanding stock option of Old Science 37 was converted into a corresponding option to purchase shares of the Issuer's Common Stock as adjusted for the Conversion Ratio.
- [F2]Stock Option is currently vested and exercisable as to 1,370,560 of the underlying shares, and the remainder will vest in equal monthly installments until fully vested on November 18, 2023, subject to the executive's continued service through the vesting date.
Documents
Issuer
Science 37 Holdings, Inc.
CIK 0001819113
Entity typeother
Related Parties
1- filerCIK 0001886837
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 9:58 PM ET
- Size
- 7.8 KB